ArticleIEEE transactions on power electronics2022
Reduced Collateral Tissue Damage Using Thermal-Feedback-Based Power Adaptation of an Electrosurgery Inverter.
Article in IEEE transactions on power electronics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 15 citations in OpenAlex.
- MCU-based Safer Coagulation Mode by Nonfixed Duty Cycle for an Electrosurgery Inverter.IEEE transactions on power electronics · 2024Article
- Radiofrequency ablation with sine and square electrical waveforms to enhance ablation range.Frontiers in bioengineering and biotechnology · 2024Article
- Output Power Computation and Adaptation Strategy of an Electrosurgery Inverter for Reduced Collateral Tissue Damage.IEEE transactions on bio-medical engineering · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Well-selected power with accurate delivery is of importance in electrosurgery to generate proper temperature at the cutting site, and thus, reduce undesired collateral tissue damages. Conventional electrosurgery generator (ESG) targets tracking a preset power, manually set by surgeons per their experience before the surgery, with high accurate delivery. It is possible that this fixed power setting is not at the optimal point and, thus, increases the possibility of added-collateral biomedical tissue damage. To eliminate the potential negative impact of the fixed and ill-suited power setting, a real-time feedback control scheme is outlined in this article to adjust the preset power of the ESG to create an adaptive power reference, which is then tracked using an experimental high-frequency inverter (HFI) that enables electrosurgery with a fundamental (sinusoidal) output frequency of 390 kHz. Subsequently, experiments using the gallium nitride (GaN)-based HFI are carried out to demonstrate the efficacy of the new variable-power approach over the conventional fixed power approach in terms of collateral tissue damage reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.